1. Home
  2. LAES vs FDMT Comparison

LAES vs FDMT Comparison

Compare LAES & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SEALSQ Corp

LAES

SEALSQ Corp

HOLD

Current Price

$2.83

Market Cap

675.0M

Sector

Technology

ML Signal

HOLD

Logo 4D Molecular Therapeutics Inc.

FDMT

4D Molecular Therapeutics Inc.

HOLD

Current Price

$12.30

Market Cap

695.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LAES
FDMT
Founded
2022
2013
Country
Switzerland
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
675.0M
695.3M
IPO Year
2022
2019

Fundamental Metrics

Financial Performance
Metric
LAES
FDMT
Price
$2.83
$12.30
Analyst Decision
Buy
Strong Buy
Analyst Count
1
7
Target Price
$4.00
$31.71
AVG Volume (30 Days)
18.2M
1.1M
Earning Date
03-31-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
18.79
EPS
N/A
N/A
Revenue
N/A
$85,209,000.00
Revenue This Year
$93.36
N/A
Revenue Next Year
$43.06
$70.28
P/E Ratio
N/A
N/A
Revenue Growth
N/A
230194.60
52 Week Low
$1.99
$4.11
52 Week High
$8.71
$14.00

Technical Indicators

Market Signals
Indicator
LAES
FDMT
Relative Strength Index (RSI) 40.14 59.77
Support Level $2.59 $8.52
Resistance Level $3.40 $14.00
Average True Range (ATR) 0.23 1.04
MACD -0.04 0.06
Stochastic Oscillator 11.81 60.47

Price Performance

Historical Comparison
LAES
FDMT

About LAES SEALSQ Corp

SEALSQ Corp develops certified secure microcontrollers and implements post-quantum cryptography. The company develops solutions including post-quantum microchips and devices that can be used in a variety of applications, from multi-factor authentication, home automation, and IT network infrastructure to automotive, industrial automation, and control systems. The company's vaultIC range offers a set of ready-to-use secure elements designed to implement embedded security for any kind of device with fast time-to-market and high flexibility. The company's products include VaultIC155, VaultIV18x, VaultIC292, and VaultIC40x. The company generates a majority of its revenue from North America, while it also has its presence in Europe, Middle East & Africa, Asia Pacific, and Latin America.

About FDMT 4D Molecular Therapeutics Inc.

4D Molecular Therapeutics Inc is biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. Companies focus is on advancing 4D-150 for wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME) through late-stage studies. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).

Share on Social Networks: